Related Experiment Video
Updated: Aug 11, 2025

Rapid In Situ Hybridization using Oligonucleotide Probes on Paraformaldehyde-prefixed Brain of Rats with Serotonin Syndrome
Published on: September 23, 2015
Serotonin 4 Receptor Brain Binding in Major Depressive Disorder and Association With Memory Dysfunction
Kristin Köhler-Forsberg1,2,3, Vibeke H Dam1,2, Brice Ozenne1,4
1Neurobiology Research Unit, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
Major depressive disorder (MDD) is linked to lower serotonin 4 (5-HT4) receptor binding in the brain. This reduced binding correlates with memory problems, suggesting 5-HT4 receptors as a potential treatment target.
Area of Science:
- Neuroscience
- Psychiatry
- Pharmacology
Background:
- The cerebral serotonin 4 (5-HT4) receptor is a potential therapeutic target for major depressive disorder (MDD).
- Stimulation of the 5-HT4 receptor may improve cognitive functions, including learning and memory.
Purpose of the Study:
- To compare cerebral 5-HT4 receptor binding in patients with untreated MDD versus healthy controls.
- To investigate the relationship between 5-HT4 receptor binding and cognitive performance in individuals with MDD.
Main Methods:
- A case-control study utilizing baseline data from the NeuroPharm clinical depression trial.
- Positron emission tomography (PET) with [11C]SB207145 was used to quantify brain 5-HT4 receptor binding in 90 MDD patients and 91 healthy controls.
- Cognitive testing, including verbal memory, was administered to MDD patients.
Main Results:
- Patients with MDD exhibited significantly lower cerebral 5-HT4 receptor binding compared to healthy controls (-7.0%, P = .002).
- A positive correlation was observed between cerebral 5-HT4 receptor binding and verbal memory performance in patients with MDD (r = 0.29, P = .02).
Conclusions:
- Cerebral 5-HT4 receptor binding is reduced in patients with untreated MDD.
- Lower 5-HT4 receptor availability is associated with memory deficits in MDD.
- The cerebral 5-HT4 receptor represents a promising therapeutic target for addressing memory dysfunction in MDD.
Related Concept Videos
G-protein Coupled Receptors
Role of Neurotransmitters in Memory
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Antidepressant Drugs: MAOIs and Other Agents
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Long-term Depression
Calcium Ion Concentration Mechanism
If over...
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists

